Sales capability

Sales enablement

Sales readiness is revealed in the moments that matter: discovery, qualification, trade-offs, and objections. Reps practice realistic scenarios and receive structured scorecards that show consistency, messaging quality, and coachable gaps for managers.

Sales enablement
Problem
Sales enablement often measures content consumption, not selling behavior. Inconsistent discovery and deal judgment reduces conversion and forecast reliability.
Outcome
More consistent selling behaviors, stronger discovery and qualification, and measurable readiness signals for coaching.
Worked example

What it looks like at Nano Masters AI Health Care Equipment

Role: Account executive selling connected patient monitoring to hospitals
Format: 15-minute discovery role-play with stakeholder branches, used at day 7, 14 and 30 for new reps
Fictional blueprint company, used for illustration.

The situation

Purchasing cycles for the company's AI-enabled monitoring are long and involve clinical leadership, biomedical engineering, IT security and procurement. The rep is in a first discovery meeting at a mid-sized hospital where nursing leaders are concerned about alarm fatigue. A competing vendor has already offered a lower unit price.

The decision

Early in the meeting, the chief nursing officer asks directly: "Can you guarantee we will see fewer false alarms?" The rest of the group is watching how the rep answers.

Option A
Avoid a guarantee, ask how alarm burden is measured today and which units are most affected, and propose a pilot measured on alert precision with a clinical specialist involved.
The CNO hears a credible path to evidence, and the rep learns who owns the metric and how a decision will be made. Discovery moves forward without an unsupported claim.
Option B
Move the discussion to price and offer a discount to neutralize the competitor.
The conversation becomes about cost before the rep understands the clinical problem or the buying group. It may keep the deal alive but weakens qualification and margin.
Option C
Say yes, to secure the CNO as a champion.
The meeting ends on a high, but the rep has made a clinical performance claim the company cannot stand behind. It creates compliance exposure and a credibility problem when biomedical engineering and quality review the proposal.

What the scorecard shows

The manager sees a scorecard by competency and, across the new-hire cohort, the most common failure modes. In this example a rep might score well on rapport but low on claim discipline and multi-stakeholder qualification, so the coaching recommendation would be a practice run focused on clinical claims and mapping the buying group before the day-30 check.

What we measure

Discovery depth
Whether the rep uncovers how the problem is measured today, where it hurts most and who owns it.
Buying group qualification
Whether the rep identifies clinical, biomedical engineering, IT security and procurement roles in the decision.
Claim discipline
Whether the rep avoids promising clinical outcomes and offers evidence-based next steps instead.
Objection handling
How the rep responds to competitor pricing without leading on discount.
Next-step control
Whether the meeting ends with a specific, agreed next step such as a scoped pilot.

FAQ

Common questions

Yes—scenarios can be aligned to your ICPs, objections, competitors, and pricing/packaging realities.

Yes—rubrics can capture clarity, empathy, prioritization, and stakeholder alignment, not just product knowledge.

Very—use it as a ramp program with readiness checks at day 7/14/30.

Cohort scorecards, common failure modes, and coaching recommendations by competency.
Want this use case tailored to your roles?
We generate scenarios, decision points, and scorecards in days.